Skip to main content
. Author manuscript; available in PMC: 2014 Apr 7.
Published in final edited form as: Clin Cancer Res. 2011 Oct 5;18(1):256–262. doi: 10.1158/1078-0432.CCR-11-1633

Table 2. Scientific productivity for phase III trials, excluding trials closed less than 7 years without a principal publication to date (n = 20).

Phase III trials, n (%)

All
N = 218
Therapeutic
n = 167
Nontherapeutic
n = 51
Resulted in principal publication 172 (79) 135 (81) 37 (73)
Answered intended scientific question 159 (73) 125 (75) 34 (67)
 Positive results 62 (39) 52 (42) 10 (29)
 Negative results 97 (61) 73 (58) 24 (71)
Inconclusive 13 (6) 10 (6) 3 (6)
Closed ≥ 7 years without a principal publication 46 (21) 32 (19) 14 (27)